Sage Therapeutics Inc (SAGE)
6.64
-0.35
(-5.01%)
USD |
NASDAQ |
Oct 04, 16:00
6.64
0.00 (0.00%)
After-Hours: 20:00
Sage Therapeutics Shareholders Equity (Annual): 799.53M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 799.53M |
| December 31, 2022 | 1.253B |
| December 31, 2021 | 1.729B |
| December 31, 2020 | 2.072B |
| December 31, 2019 | 944.66M |
| December 31, 2018 | 862.97M |
| Date | Value |
|---|---|
| December 31, 2017 | 475.48M |
| December 31, 2016 | 368.52M |
| December 31, 2015 | 173.70M |
| December 31, 2014 | 121.88M |
| December 31, 2013 | -31.54M |
| December 31, 2012 | -13.39M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
799.53M
Minimum
2023
2.072B
Maximum
2020
1.360B
Average
1.253B
Median
2022
Shareholders Equity (Annual) Benchmarks
| Biogen Inc | 14.80B |
| Outset Medical Inc | 122.89M |
| Biomarin Pharmaceutical Inc | 4.952B |
| Verastem Inc | 57.37M |
| Ardelyx Inc | 166.82M |